Holen Sie sich die Stockscreener-App
146.73
1.45%
2.15
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$144.58
Offen:
$145.95
24-Stunden-Volumen:
296.88K
Relative Volume:
0.22
Marktkapitalisierung:
$28.92B
Einnahmen:
$16.10B
Nettoeinkommen (Verlust:
$2.10B
KGV:
14.37
EPS:
10.2136
Netto-Cashflow:
$1.46B
1W Leistung:
-3.54%
1M Leistung:
-7.57%
6M Leistung:
-13.86%
1J Leistung:
+4.91%
1-Tages-Spanne:
$145.06
$146.82
1-Wochen-Bereich:
$144.20
$152.29
52-Wochen-Spanne:
$117.56
$177.66
Raymond James Financial Inc Stock (RJF) Company Profile
Firmenname
Raymond James Financial Inc
Sektor
Branche
Telefon
727-567-1000
Adresse
880 CARILLON PKWY, ST PETERSBURG, FL
Compare RJF vs BLK, BN, BX, KKR, BAM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RJF
Raymond James Financial Inc
|
146.71 | 28.50B | 16.10B | 2.10B | 1.46B | 10.21 |
|
BLK
Blackrock Inc
|
932.06 | 143.55B | 24.92B | 5.94B | 3.75B | 35.00 |
|
BN
Brookfield Corporation
|
38.77 | 87.00B | 77.49B | 3.24B | -2.78B | 0.4932 |
|
BX
Blackstone Inc
|
106.64 | 79.98B | 14.02B | 6.05B | 1.74B | 3.8674 |
|
KKR
Kkr Co Inc
|
86.05 | 74.78B | 20.26B | 6.15B | 9.52B | 2.3271 |
|
BAM
Brookfield Asset Management Ltd
|
43.35 | 70.67B | 4.82B | 2.40B | 2.28B | 1.5287 |
Raymond James Financial Inc Stock (RJF) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-28 | Eingeleitet | Barclays | Overweight |
| 2025-12-11 | Fortgesetzt | UBS | Neutral |
| 2025-10-03 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-04-30 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-01-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-01-06 | Hochstufung | Goldman | Neutral → Buy |
| 2024-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-10-09 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2024-09-12 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-01-10 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2024-01-09 | Herabstufung | Jefferies | Buy → Hold |
| 2024-01-04 | Eingeleitet | TD Cowen | Market Perform |
| 2024-01-03 | Herabstufung | Goldman | Buy → Neutral |
| 2023-09-19 | Eingeleitet | JP Morgan | Neutral |
| 2023-09-11 | Eingeleitet | BofA Securities | Buy |
| 2023-07-21 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-12-19 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2022-11-22 | Eingeleitet | UBS | Neutral |
| 2022-10-19 | Eingeleitet | Credit Suisse | Neutral |
| 2022-10-12 | Eingeleitet | Citigroup | Neutral |
| 2022-01-28 | Hochstufung | Seaport Research Partners | Neutral → Buy |
| 2022-01-10 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2021-07-21 | Eingeleitet | Jefferies | Buy |
| 2021-01-15 | Hochstufung | Wells Fargo | Underweight → Overweight |
| 2021-01-05 | Hochstufung | Goldman | Sell → Buy |
| 2021-01-05 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-11-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-07-08 | Eingeleitet | Seaport Global Securities | Neutral |
| 2020-06-09 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-05-01 | Herabstufung | Compass Point | Buy → Neutral |
| 2020-03-25 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-03-25 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-03-24 | Herabstufung | Goldman | Neutral → Sell |
| 2020-03-06 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-03-04 | Herabstufung | Citigroup | Neutral → Sell |
| 2019-11-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2019-03-06 | Eingeleitet | Argus | Buy |
| 2018-11-27 | Eingeleitet | Goldman | Neutral |
| 2018-10-26 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-07-27 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2018-07-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-05-16 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-27 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2018-04-10 | Eingeleitet | Bernstein | Mkt Perform |
| 2018-02-27 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
Alle ansehen
Raymond James Financial Inc Aktie (RJF) Neueste Nachrichten
Esquire Financial raised to Strong Buy at Raymond James on Signature acquisition (ESQ:NASDAQ) - Seeking Alpha
Raymond James Adjusts PT on Akamai Technologies to $120 From $100, Maintains Outperform Rating - marketscreener.com
Sei Investments Co. Purchases 25,018 Shares of Raymond James Financial, Inc. $RJF - MarketBeat
Raymond James Financial Stock: Is RJF Underperforming the Financial Sector? - Yahoo Finance
Raymond James Adjusts Price Target on Dollar General to $155 From $135, Maintains Outperform Rating - marketscreener.com
Raymond James upgrades Korro Bio stock rating on hyperammonemia pivot - Investing.com
Bank of Montreal Can Grows Stock Holdings in Raymond James Financial, Inc. $RJF - MarketBeat
Raymond James Reiterates Strong Buy for WSBC WesBanco, Inc. March 2026 - Meyka
Oscar Health Valuation After Raymond James Upgrade And Margin Expansion Outlook - simplywall.st
Raymond James raises Guardian Pharmacy shares price target on vaccine program strength - Investing.com
Why Raymond James left more confident in WEX’s (WEX) 2026 growth path - MSN
Raymond James reiterates WesBanco stock Strong Buy on Florida expansion - Investing.com
Why Raymond James Left More Confident in WEX’s (WEX) 2026 Growth Path - Yahoo Finance
Med Tech pricing turns flat after brief positive trend, says Raymond James - Investing.com Canada
Raymond James Sticks to Their Buy Rating for Williams Co (WMB) - The Globe and Mail
Geneva Capital Management LLC Raises Stock Position in Raymond James Financial, Inc. $RJF - MarketBeat
Raymond James raises Viant Technology stock price target on strong Q4 - Investing.com
Farmland Partners (FPI): Analyst Downgrade by Raymond James | FP - GuruFocus
Schroder Investment Management Group Buys 9,238 Shares of Raymond James Financial, Inc. $RJF - MarketBeat
Raymond James Financial, Inc. $RJF Shares Sold by Inceptionr LLC - MarketBeat
Raymond James cuts Farmland Partners stock rating on valuation - Investing.com
Raymond James Starts ALMS (Alumis Inc. Common Stock) at Strong Buy Mar 2026 - Meyka
Raymond James starts Climb Bio, Inc. (CLYM) at Strong Buy March 2026 - Meyka
Raymond James Maintains Strong Buy on Ulta Beauty, Inc. (ULTA) March 2026 - Meyka
Raymond James Downgrades Optimum Communications (OPTU) to Market Perform 3/2026 - Meyka
Raymond James upgrades Oscar Health, Inc. (OSCR), UBS lowers PT - MSN
Investor Alert: Investment Concerns Involving Mario Joseph Payne and Raymond James Financial Services - Levin Papantonio
February Market Review - montgomerycountynews.net
Royal Gold (RGLD) Valuation Check After Raymond James Conference And Growth Project Updates - simplywall.st
Raymond James Adjusts Price Target on Vistra to $240 From $248, Maintains Strong Buy Rating - marketscreener.com
Raymond James (NYSE:RJF) Strategic Moves Across The Russell 1000 Index Arena - Kalkine Media
Raymond James initiates Alumis stock coverage citing psoriasis drug potential - Investing.com
Constellation Software (TSE:CSU) Given New C$3,700.00 Price Target at Raymond James Financial - MarketBeat
Royal Gold, Inc. (RGLD) CEO Highlights Strong Results at Raymond James Conference - Finviz
Dianthus Therapeutics (NASDAQ:DNTH) Raised to Strong-Buy at Raymond James Financial - MarketBeat
Headlines Bring Perspective… Actions Capture OpportunityRaymond JamesCommentaries - Advisor Perspectives
Jefferies Financial Group Inc. Purchases 33,063 Shares of Raymond James Financial, Inc. $RJF - MarketBeat
Vinva Investment Management Ltd Acquires Shares of 15,519 Raymond James Financial, Inc. $RJF - MarketBeat
Natixis Advisors LLC Increases Stake in Raymond James Financial, Inc. $RJF - MarketBeat
Korea Investment CORP Boosts Stake in Raymond James Financial, Inc. $RJF - MarketBeat
Raymond James Financial, Inc. (NYSE:RJF) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Raymond James names AQNU (Algonquin Power & Utilities Corp.) Outperform Mar 2026 - Meyka
Raymond James Maintains Strong Buy on KLRS Kalaris Therapeutics Inc Mar 2026 - Meyka
Raymond James Maintains Strong Buy on Biohaven Ltd. (BHVN) March 2026 - Meyka
Raymond James reiterates Strong Buy on Biohaven stock after competitor data - Investing.com
Lynn Pippenger, former Raymond James CFO and major USF donor, has died - The Business Journals
Raymond James reiterates Strong Buy on Kalaris stock amid trial delay - Investing.com
Raymond James reiterates Engene Holdings stock Strong Buy rating - Investing.com
Raymond James Financial Forecasts Strong Price Appreciation for Coterra Energy (NYSE:CTRA) Stock - MarketBeat
Raymond James Financial Upgrades Alta Equipment Group (NYSE:ALTG) to Outperform - MarketBeat
Raymond James initiates ARKO stock with Strong Buy on growth potential - Investing.com
Finanzdaten der Raymond James Financial Inc-Aktie (RJF)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.22%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):